Cargando…
PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
Despite improvement of therapeutic treatments for breast cancer, the development of brain metastases has become a major limitation to life expectancy for many patients. Brain metastases show very commonly alterations in EGFR and HER2 driven pathways, of which PTEN is an important regulator. Here, we...
Autores principales: | Hohensee, Ina, Chuang, Han-Ning, Grottke, Astrid, Werner, Stefan, Schulte, Alexander, Horn, Stefan, Lamszus, Katrin, Bartkowiak, Kai, Witzel, Isabell, Westphal, Manfred, Matschke, Jakob, Glatzel, Markus, Jücker, Manfred, Pukrop, Tobias, Pantel, Klaus, Wikman, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351620/ https://www.ncbi.nlm.nih.gov/pubmed/28008153 http://dx.doi.org/10.18632/oncotarget.14047 |
Ejemplares similares
-
Relevance of PTEN loss in brain metastasis formation in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2012) -
Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012) -
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2014) -
Clonality of circulating tumor cells in breast cancer brain metastasis patients
por: Riebensahm, Carlotta, et al.
Publicado: (2019) -
Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations
por: Westphal,, Manfred, et al.
Publicado: (2022)